Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy

Bladder cancer is one of the most common malignant tumors in urinary system. Intravesical chemotherapy is a common adjuvant therapy after transurethral resection of bladder tumors. However, it has several disadvantages such as low drug penetration rate, short residence time, unsustainable action and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yilei, Wang, Siqi, Wang, Yuhang, Li, Mingshan, Liu, Yili, Xue, Dongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202556/
https://www.ncbi.nlm.nih.gov/pubmed/35720013
http://dx.doi.org/10.3389/fonc.2022.879828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202556/
https://www.ncbi.nlm.nih.gov/pubmed/35720013
http://dx.doi.org/10.3389/fonc.2022.879828

Ejemplares similares